Raltegravir (Isentress) Pilot Study in Relapsing Multiple Sclerosis (INSPIRE)
This study is not yet open for participant recruitment.
Verified January 2013 by Queen Mary University of London
Sponsor:
Queen Mary University of London
Collaborator:
Merck
Information provided by (Responsible Party):
Gavin Giovannoni, Queen Mary University of London
ClinicalTrials.gov Identifier:
NCT01767701
First received: January 7, 2013
Last updated: January 25, 2013
Last verified: January 2013
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Study Status: | This study is not yet open for participant recruitment. |
|---|---|
| Estimated Study Completion Date: | August 2014 |
| Estimated Primary Completion Date: | August 2014 (Final data collection date for primary outcome measure) |